Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

Blood

Volumn 118, Issue 5, 2011, Pages 1421-1428

  Sanders, Jean E ^a   Woolfrey, Ann E ^a   Carpenter, Paul A ^a   Storer, Barry E ^a   Hoffmeister, Paul A ^a   Deeg, H Joachim ^a   Flowers, Mary E D ^a   Storb, Rainer F ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; PROCARBAZINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER SURVIVAL; CANCER SURVIVOR; CAUSE OF DEATH; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEALTH INSURANCE; HEMOLYTIC ANEMIA; HEPATITIS C; HLA MATCHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; HYPOTHYROIDISM; LATE EFFECT; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MEASLES PNEUMONIA; PNEUMONIA; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGENY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; SUICIDE; SURVIVAL TIME; THERAPY EFFECT; THYROID FUNCTION TEST; TREATMENT OUTCOME; UTERINE CERVIX CANCER; WHOLE BODY RADIATION;

EID: 80051553275     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-334953     Document Type: Article

References (31)

1. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70.
2. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84(3):941-949. (Pubitemid 24223895)
3. Young NS. Acquired aplastic anemia [review]. Ann Intern Med. 2002;136(7):534-546. (Pubitemid 34252288)
4. Storb R, Deeg HJ, Pepe M, et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial. Br J Haematol. 1989;72(4):567-572. (Pubitemid 19220499)
5. Kröger N, Zabelina T, Renges H, et al. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Ann Hematol. 2002;81(11):627-631. (Pubitemid 36075516)
6. Fouladi M, Herman R, Rolland-Grinton M, et al. Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplant. 2000;26(11):1149-1156.
7. Burroughs L, Woolfrey A, Storer B, et al. Improved survival following HLA-matched related marrow transplantation in pediatric patients with severe aplastic anemia: (A 39-year retrospective analysis) [abstract]. Biol Blood Marrow Transplant. 2011;17:S264, #302.
8. Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91(10):3637-3645. (Pubitemid 28225730)
9. Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103(7):2490-2497. (Pubitemid 38392998)
10. Socié G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation [review]. Blood. 2003;101(9):3373- 3385. (Pubitemid 36857917)
11. Sanders JE, Hoffmeister PA, Woolfrey AE, et al. Thyroid function following hematopoeitic cell transplantation in children: 30 years experience. Blood. 2009;113(2):306-308.
12. Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 2008;41(2):223-227. (Pubitemid 351188921)
13. Sanders JE, Whitehead J, Storb R, et al. Bone marrow transplantation experience for children with aplastic anemia. Pediatrics. 1986;77(2):179-186. (Pubitemid 16212867)
14. Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood. 1982;59(2):236-246. (Pubitemid 12172009)
15. Deeg HJ, Self S, Storb R, et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Blood. 1986;68(6):1363-1368. (Pubitemid 17228816)
16. Storb R, Thomas ED, Weiden PL, et al. One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle. Transplant Proc. 1978;10(1):135-140. (Pubitemid 8306627)
17. Sullivan KM, Witherspoon RP, Storb R, et al. Chronic graft-versus-host disease: recent advances in diagnosis and treatment. In: Gale RP, Champlin R, eds. Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series. New York, NY: Alan R. Liss, Inc; 1989:511-522.
18. Loughran TP Jr, Sullivan K, Morton T, et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood. 1990;76(1):228-234. (Pubitemid 20220815)
19. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant. 2010;45(4):746-754.
20. Hoffmeister PA, Madtes DK, Storer BE, Sanders JE. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer. 2006;47(5):594-606. (Pubitemid 44360061)
21. Piccin A, McCann S, Socie G, et al. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT. Bone Marrow Transplant. 2010;45(6):1008-1013.
22. Curtis RE, Metayer C, Rizzo JD, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stemcell transplantation: an international case-control study. Blood. 2005;105(10):3802-3811. (Pubitemid 40662691)
23. Leisenring W, Friedman DL, Flowers MED, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24(7):1119-1126. (Pubitemid 46638809)
24. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, MD: National Cancer Institute, National Institutes of Health Pub. No. 06-5767; 2006.
25. Sanders JE. Growth and development after hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, UK: Wiley-Blackwell; 2009:1608-1619.
26. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87(7):3045-3052.
27. Loren AW, Chow E, Jacobsohn DA, et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2011;17(2):157-156.
28. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254-1259. (Pubitemid 26147662)
29. Carpenter PA, Hoffmeister P, Chesnut CH III, et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13(9):683-690. (Pubitemid 46767996)
30. Felder-Puig R, Peters C, Matthes-Martin S, et al. Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation. Bone Marrow Transplant. 1999;24(1):75-80. (Pubitemid 29346609)
31. Nespoli L, Verri AP, Locatelli F, Bertuggia L, Taibi RM, Burgio GR. The impact of paediatric bone marrow transplantation on quality of life. Qual Life Res. 1995;4(3):233-240.